Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a ...

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients ...

Many conventional small-molecule drugs work by inhibiting proteins, affecting their function. One small molecule instead imbues a protein with a new function in a mechanism that could inform ...

Anthony Bartell, a partner at McCarter & English and ... doctors and drug distributors that failed to maintain effective controls over their drugs,” one insurance law expert said.

A New Psychoactive Substance (NPS) is a substance of abuse, either in a pure form or a preparation, that is not controlled by the 1961 Single Convention on Narcotic Drugs or the 1971 Convention on ...